A Review of Chimeric Antigen Receptor T-Cell Therapy for Myeloma and Lymphoma - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/33814917/
1 Plasma Cell Disorders Division, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA. 2 Lymphoma Division, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA. Free PMC article Free PMC article 1 Plasma Cell Disorders Division, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA.
-
Mark FeslerApril 11, 2021A very nice review of car T cell therapy as pertains to what are likely to be the most common indications in the very near future